Doxil, Gemcitabine, and Velcade (PS341) in Advanced Cancer Patients

NCT00500422 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

134

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: Doxil
DRUG: Gemcitabine
DRUG: Velcade

Sponsor

M.D. Anderson Cancer Center